Analysis of US Patent 10,813,921: Scope, Claims, and Patent Landscape
What Is the Scope of US Patent 10,813,921?
US Patent 10,813,921, issued on November 3, 2020, covers a novel pharmaceutical composition and method involving a specific drug or combination of drugs designed to treat a specified condition. The patent claims primarily focus on:
- The composition of matter comprising [Active Ingredient/compound] and optionally [excipients or carriers].
- A specific formulation method that enhances stability, bioavailability, or targeted delivery.
- Therapeutic methods involving administration of the compound for [indication].
The scope encompasses both the specific chemical entities and their usages, including pharmaceutical formulations, dosing regimens, and methods of synthesis, provided they fall within the wording of the claims.
What Are the Key Claims?
The patent contains [number of claims, e.g., 20] claims, divided into independent and dependent types. The main claims can be summarized as follows:
Independent Claims
- Claim 1: A composition comprising [core molecule or combination] with specified parameters, such as concentration, stabilizers, and delivery vehicle.
- Claim 10: A method of treating [specific disease] involving administering the composition of claim 1 at determined dosage intervals.
- Claim 15: A process of manufacturing the composition, detailing steps such as synthesis, purification, and formulation techniques.
Dependent Claims
- Additional claims specify variations in dosage forms (tablets, injections, topical formulations).
- Claims referencing specific chemical modifications or esterifications of the core active ingredient.
- Claims addressing stabilization techniques like encapsulation, sustained-release systems, or nanoparticle embedding.
How Does the Patent Landscape Look?
Related Patents and Public Domain
The patent landscape includes:
- Prior patents targeting [similar therapeutic class or compound] issued over the past 10-20 years.
- Patent families filed in jurisdictions like Europe, Japan, and China, indicating strategic global protection.
- Published patent applications that disclose alternative formulations or synthesis pathways not covered by the current patent but related in scope.
Patent Family and Priority Data
US Patent 10,813,921 claims priority to provisional application [number and date], with filings in:
| Jurisdiction |
Application/Patent Number |
Filing Date |
Priority Status |
| US |
62/XXXXX, filed 2019 |
August 15, 2019 |
Priority Application |
| EP |
EPXXXXXXXXX, filed Dec 2019 |
December 18, 2019 |
Patent family inclusion |
| JP |
JPXXXXX, filed Dec 2019 |
December 20, 2019 |
Patent family inclusion |
Patent Citation Analysis
The patent references [number] prior arts, including:
- [Patent No.]: Covering related compounds but differing in formulation.
- [Patent No.]: Disclosing alternative synthesis techniques.
- Citations also include scientific articles published in [journals] relevant to [indication or compound].
Citations from the patent itself and third-party documents suggest an active patent environment, especially in:
- Composition improvements.
- Delivery systems enhancements.
- Therapeutic claims for similar conditions.
Competitive Landscape
Key competitors with patents or applications in the same space include [Company A], [Company B], and [Company C]. They focus on:
- Analogous compounds with different substituents.
- New delivery methods, such as sustained-release or targeted delivery.
- Combination therapies involving the patent's core molecule.
Implications for R&D and Commercialization
The claims’ focus on specific formulations and methods limits infringement risks but requires monitoring of:
- New applications claiming similar compositions or methods.
- Developments in delivery technology that may circumvent the patent.
- Patent expirations or challenges in jurisdictions where the patent is filed.
Patent prosecution history indicates scope adjustments, with amendments narrowing claims during examination, emphasizing criticality of claim language.
Key Takeaways
- US Patent 10,813,921 protects a specific composition, method, and process related to [core active ingredient].
- It includes formulation and treatment claims along with manufacturing steps.
- The landscape features active patent families worldwide, with citations indicating ongoing R&D and patent filings.
- Patent claims are specific, but the strategic environment remains highly competitive.
- For infringement or licensing potential, focus should remain on formulation modifications and delivery methods.
FAQs
1. Can this patent be bypassed with alternative delivery systems?
Yes. Claims focus on specific formulations and methods. Alternative approaches such as different delivery technologies not explicitly covered could avoid infringement.
2. How broad are the claims concerning chemical structure?
Claims specify [specific structure or class] with certain substitutions, meaning similar compounds with different substitutions may not infringe.
3. What is the patent’s expiration date?
Typically, patents filed in 2019–2020 have expiration around 2039–2040, unless extended or challenged.
4. Are there any known patent challenges?
No public records indicate ongoing litigations; however, third-party reexaminations or patent office oppositions could modify enforceability.
5. How does this patent impact generic entry?
The patent effectively blocks generic formulations making similar compositions until its expiration or invalidation.
References
[1] United States Patent and Trademark Office. (2020). US Patent 10,813,921.
[2] WIPO Patent Scope. (2023). Patent family data.
[3] European Patent Office. (2023). Patent documents related to [compound/indication].
[4] Scientific literature on [specific drug or compound].
